- $2.25bn
- $3.13bn
- $2.72bn
Fortrea beats Q2 revenue estimates, raises 2025 guidance
Brief: Fortrea & Emery Pharma Announce Strategic Collaboration To Deliver FDA Compliant Drug
Brief: Fortrea Names Anshul Thakral Chief Executive Officer
Advisory: Incorrect outlook alerts on Fortrea from law firm's release withdrawn
Fortrea Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Fortrea Q1 Net Income USD -562.9 Million
Brief: Fortrea Announces CEO Stepping Down
U.S. RESEARCH ROUNDUP-Lowe's Companies, Netflix, Vulcan Materials
U.S. STOCKS ON THE MOVE-THOR Industries, TG Therapeutics, Target
U.S. STOCKS ON THE MOVE-Melco Resorts, Chipotle, Allegro
Fortrea Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Fortrea hits record low after forecasting 2025 revenue below estimate
U.S. STOCKS ON THE MOVE-Tesla, SolarEdge ,Protagonist
Fortrea tumbles on weak 2025 revenue forecast
Brief: Jana Partners Cuts Share Stake In FIS, Wolfspeed; Dissolves Share Stake In Fortrea Holdings
Brief: Maravai Lifesciences Appoints R. Andrew Eckert As Chairman Of The Board Of Directors
U.S. RESEARCH ROUNDUP-Domino's Pizza, Elastic NV, Snowflake
U.S. STOCKS ON THE MOVE-Fortinet, Molson Coors, Corpay
Fortrea Holdings Inc reports results for the quarter - Earnings Summary